- Home
- CRWD vs PFE Comparison
CRWD vs PFE Comparison
Compare CRWD & PFE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CRWD | PFE |
|---|---|---|
| Founded | 2011 | 1849 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | EDP Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 174.3B | 147.6B |
| IPO Year | 2019 | 2013 |
Fundamental Metrics
Financial Performance| Metric | CRWD | PFE |
|---|---|---|
| Price | $240.66 | $27.54 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 48 | 14 |
| Target Price | ★ $507.00 | $29.29 |
| AVG Volume (30 Days) | 10.7M | ★ 25.7M |
| Earning Date | 06-02-2026 | 05-05-2026 |
| Dividend Yield | N/A | ★ 6.55% |
| EPS Growth | N/A | ★ N/A |
| EPS | 0.03 | ★ 0.43 |
| Revenue | $4,812,005,000.00 | ★ $62,579,000,000.00 |
| Revenue This Year | $24.85 | N/A |
| Revenue Next Year | $21.40 | N/A |
| P/E Ratio | $8,074.67 | ★ $64.02 |
| Revenue Growth | ★ 21.71 | N/A |
| 52 Week Low | $174.14 | $23.59 |
| 52 Week High | $786.00 | $29.21 |
Technical Indicators
Market Signals| Indicator | CRWD | PFE |
|---|---|---|
| Relative Strength Index (RSI) | 58.41 | 50.20 |
| Support Level | $178.38 | $26.42 |
| Resistance Level | $450.27 | $27.75 |
| Average True Range (ATR) | 13.02 | 0.47 |
| MACD | 6.46 | -0.20 |
| Stochastic Oscillator | 97.28 | 14.50 |
Price Performance
Historical ComparisonAbout CRWD CrowdStrike Holdings Inc.
CrowdStrike is a cloud-native cybersecurity company specializing in security verticals such as endpoint, cloud workload, identity, and security operations. CrowdStrike's primary offering is its Falcon platform, which provides enterprises with a unified view to detect and respond to security threats across their IT infrastructure. The Austin, Texas-based firm was founded in 2011 and went public in 2019.
About PFE Pfizer Inc.
Pfizer is one of the world's largest pharmaceutical firms, with annual sales of roughly $60 billion. While it historically sold many types of healthcare products and chemicals, now prescription drugs and vaccines account for the majority of sales. Top sellers include pneumococcal vaccine Prevnar 13 and cardiology drugs Vyndaqel and Eliquis. Pfizer sells these products globally, with international sales representing 40% of total sales. Within international sales, emerging markets are a major contributor.